Practice-changing ESMO24 genitourinary trials with Anthony Joshua – Oncology for the Inquisitive Mind
Oncology for the Inquisitive Mind shared a post on X:
“Professor Anthony Joshua returns for an encore to give us a taste of the practice-changing ESMO24 genitourinary trials (which, in our opinion, stole the show).”
Listen to the podcast episode.
More posts featuring Oncology for the Inquisitive Mind.
Anthony Joshua is the Program Director of Translational Oncology and Laboratory Head of Oncology Translational Research at the Garvan Institute of Medical Research. He is also a conjoint Professor at UNSW Sydney.
Previously, he served as a staff oncologist at the Princess Margaret Cancer Centre in Toronto, focusing on genitourinary malignancies and melanoma. His research includes circulating tumor DNA, tumor heterogeneity, enzalutamide resistance mechanisms, and autophagy.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023